CERRITO, MARIA GRAZIA
CERRITO, MARIA GRAZIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022 Scagliotti, A; Capizzi, L; Cazzaniga, M; Ilari, A; De Giorgi, M; Cordani, N; Gallazzi, M; Bruno, A; Pelosi, G; Albini, A; Lavitrano, M; Grassilli, E; Cerrito, M
Emerging actionable targets to treat therapy-resistant colorectal cancers
2022 Grassilli, E; Cerrito, M
BTK, the new kid on the (oncology) block?
2022 Grassilli, E; Cerrito, M; Lavitrano, M
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
2022 Cazzaniga, M; Capici, S; Cordani, N; Cogliati, V; Fulvia Pepe, F; Riva, F; Cerrito, M
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity
2022 Benedetto, N; Calabrone, L; Gutmanska, K; Macri, N; Cerrito, M; Ricotta, R; Pelosi, G; Bruno, A; Noonan, D; Albini, A
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story
2022 Cogliati, V; Capici, S; Pepe, F; Di Mauro, P; Riva, F; Cicchiello, F; Maggioni, C; Cordani, N; Cerrito, M; Cazzaniga, M
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
2022 Pepe, F; Cazzaniga, M; Baroni, S; Riva, F; Cicchiello, F; Capici, S; Cogliati, V; Maggioni, C; Cordani, N; Cerrito, M; Malandrin, S
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
2021 Grassilli, E; Cerrito, M; Bonomo, S; Giovannoni, R; Conconi, D; Lavitrano, M
Metronomic chemotherapy
2021 Cazzaniga, M; Cordani, N; Capici, S; Cogliati, V; Riva, F; Cerrito, M
Identifying novel actionable targets in colon cancer
2021 Cerrito, M; Grassilli, E
Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome?
2020 Formica, F; Mariani, S; D'Alessandro, S; Singh, G; Di Mauro, M; Cerrito, M; Messina, L; Scianna, S; Papesso, F; Sangalli, F
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers
2020 Lavitrano, M; Ianzano, L; Bonomo, S; Cialdella, A; Cerrito, M; Pisano, F; Missaglia, C; Giovannoni, R; Romano, G; Mclean, C; Voest, E; D'Amato, F; Noli, B; Ferri, G; Agostini, M; Pucciarelli, S; Helin, K; Leone, B; Canzonieri, V; Grassilli, E
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation
2020 Scagliotti, A; Grassilli, E; Cazzaniga, M; Capizzi, L; Lavitrano, M; Cerrito, M
Sperm-Mediated Genetic Modifications
2020 Lavitrano, M; Farina, L; Cerrito, M; Giovannoni, R
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer
2019 Basile, D; Gerratana, L; Buonadonna, A; Garattini, S; Perin, T; Grassilli, E; Miolo, G; Cerrito, M; Belluco, C; Bertola, G; De Paoli, A; Cannizzaro, R; Lavitrano, M; Puglisi, F; Canzonieri, V
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 Giordano, F; Vaira, V; Cortinovis, D; Bonomo, S; Goedmakers, J; Brena, F; Cialdella, A; Ianzano, L; Forno, I; Cerrito, M; Giovannoni, R; Ferri, G; Tasciotti, E; Vicent, S; Damarco, F; Bosari, S; Lavitrano, M; Grassilli, E
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
2019 Sala, L; Cirillo, G; Riva, G; Romano, G; Giussani, C; Cialdella, A; Todisco, A; Virtuoso, A; Cerrito, M; Bentivegna, A; Grassilli, E; Ardizzoia, A; Bonoldi, E; Giovannoni, R; Papa, M; Lavitrano, M
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Minimal Extracorporeal Circulation and Minimally Invasive Valve Operations: Should They Be the Right Combination in the Future?
2017 Formica, F; Broccolo, F; Cerrito, M
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro
2017 Chisci, E; De Giorgi, M; Zanfrini, E; Testasecca, A; Brambilla, E; Cinti, A; Farina, L; Kutryb Zając, B; Bugarin, C; Villa, C; Grassilli, E; Combi, R; Gaipa, G; Cerrito, M; Rivolta, I; Smolenski, R; Lavitrano, M; Giovannoni, R